Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Inj. Imiglucerase 400 units | TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED | 1 | ₹33.3 L |
| 2 | Inj. Idursulfase 2 mg per ml, 3 ml vial | TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED | 1 | ₹33.3 L |
Tender Value
₹43.6 L
EMD Value
Exempted
Closing Date
4 Sept 2024, 3:00 pmClosed
Medicine
6750654
GEM/2024/B/5260738
Two Packet Bid
Inj. Imiglucerase 400 units,Tab. Rucaparib 250 mg,Tab. Lorlatinib 100 mg,Inj.Idursulfase 2mg per ml
GeM Contract
15 days
Maharashtra; Pune
Group wise evaluation
BOQ
Awarded to TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED
₹33.3 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Inj.Idursulfase 2mg per ml, 3 ml vial | Elaprase / Idursulfase (r-DNA origin) -2mg/mL (2 MG/ML, 3.0 ML INJ) | 30049099 | 24 vial | 138,880 | 3,333,120 |
Awarded to SANOFI HEALTHCARE INDIA PRIVATE LIMITED
₹5.4 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Inj. Imiglucerase 400 units | Sanofi Healthcare India Pvt. Ltd / Cerezyme | 30049099 | 8 vial | 66,950.1 | 535,600.8 |
7 documents required · 7 mandatory
3 yrs
₹3
Exempted
4 Oct 2024
14 Aug 2024
4 Sept 2024
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Inj. Imiglucerase 400 units | Inj. Imiglucerase 400 units | 8 | vial | ESICHOPBIBPUNE@MED3 | 15 |
| 2 | Tab. Rucaparib 250 mg | Tab. Rucaparib 250 mg | 360 | tablet | ESICHOPBIBPUNE@MED3 | 15 |
| 3 | Tab. Lorlatinib 100 mg | Tab. Lorlatinib 100 mg | 90 | tablet | ESICHOPBIBPUNE@MED3 | 15 |
| 4 | Inj.Idursulfase 2mg per ml, 3 ml vial | Inj.Idursulfase 2mg per ml,3 ml vial | 24 | vial | ESICHOPBIBPUNE@MED3 | 15 |
| 5 | Inj. Dextrose 5 percent 500 ml | Inj. Dextrose 5 percent 500 ml | 113 | pack | ESICHOPBIBPUNE@MED3 | 15 |
| 6 | Sodium Chloride Inj 0.9 percent - 500 ml | Sodium Chloride Inj 0.9 percent - 500 ml | 1,000 | pack | ESICHOPBIBPUNE@MED3 | 15 |
| 7 | Sodium Chloride Inj 0.9 percent and Dextrose 5 percent - 500 ml | Sodium Chloride Inj 0.9 percent and Dextrose 5 percent - 500 ml | 950 | pack | ESICHOPBIBPUNE@MED3 | 15 |
| 8 | Inj. Dextrose Anhydrous 25 percent wv 100 ml | Inj. Dextrose Anhydrous 25 percent wv 100 ml | 80 | pack | ESICHOPBIBPUNE@MED3 | 15 |
contract_GEMC-511687791415858.pdf
GEM_CONTRACT • 0.08 MB
contract_GEMC-511687784165231.pdf
GEM_CONTRACT
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6750654.pdf
GEM_BID
items_specifications_iv_fluid_and_ert_2024-08-07-11-56-41_535a2955e0261ad9d1a73ec436ba8e70.pdf
BOQ
boq_ert_and_ivfluids__drugs_bid_2024-08-07-11-56-41_31f5426f063d8cbbb2c8bef8cec5875c.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .